A New Efficient Method for the Total Synthesis of Linear Furocoumarins

Bang-Le Zhang; Fang-Dao Wang; Jian-Min Yue

doi:10.1055/s-2006-926250

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2006(4): 0567-0570
DOI: 10.1055/s-2006-926250

LETTER

A New Efficient Method for the Total Synthesis of Linear Furocoumarins

Bang-Le Zhang^a,b, Fang-Dao Wang^a, Jian-Min Yue*^a
^a State Key Laboratory of Drug Research, Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 555 Zuchongzhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, P. R. of China
^b Department of Pharmacology, Fourth Military Medical University, Xi’an Shaanxi 710032, P. R. of China
Fax: +86(21)50806718; e-Mail: jmyue@mail.shcnc.ac.cn;

Further Information

Publication History

Received 15 November 2005
Publication Date:
20 February 2006 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A new efficient method for the synthesis of linear furocoumarins by a Nef reaction and intramolecular cyclocondensation in one pot results in the construction of a benzofuran ring. This method provides a new strategy to furnish the benzofuran framework easily, and also allows the convenient synthesis of furocoumarin derivatives with different substituents on the coumarin ring by a subsequent Pechmann reaction. This strategy has also been applied to the preparation of four additional benzofuran derivatives.

Key words

Nef reaction - Pechmann reaction - furocoumarins - total synthesis - intramolecular cyclocondensation

References and Notes

1 Bethea D. Fullmer B. Syed S. Seltzer G. Tiano J. Rischko C. Gillespie L. Brown D. Gasparro FP. J. Dermatol. Sci. 1999, 19: 78

Crossref Google Scholar
2a Grundmann KM. Ludwig R. Zollner TM. Ochsendorf F. Thaci D. Boehncke WH. Krutmann J. Kaufmann R. Podda M. J. Am. Acad. Dermatol. 2004, 50: 734

Crossref Google Scholar
2b Grimes PE. Clin. Dermatol. 1997, 15: 921

Crossref Google Scholar
2c Petering H. Breuer C. Herbst R. Kapp A. Werfel T. J. Am. Acad. Dermatol. 2004, 50: 68

Crossref Google Scholar
3a Diederen PVMM. Weelden H. Sanders CJG. Toonstra J. Vloten WA. J. Am. Acad. Dermatol. 2003, 48: 215

Google Scholar
3b Miolo G. Tomanin R. Rossi AD. Dall AF. Zacchello F. Scarpa M. J. Photochem. Photobiol. B 1994, 26: 241

Google Scholar
3c Lage C. Pádula M. Alencar TAM. Gonçalves SRF. Vidal LS. Cabral-Neto J. Leitão AC. Mutat. Res. Rev. Mutat. Res. 2003, 544: 143

Google Scholar
4 Cimino GD. Gamper HB. Isaacs ST. Hearst JE. Ann. Rev. Biochem. 1985, 54: 1151

Google Scholar
5 Edelson RL. Arch. Dermatol. 1999, 135: 600

Crossref Google Scholar
6a Goupil JJ. inventors; French Patent 2:698,270.
6b Goaster JL. inventors; French Patent 2:691,629.
7 Wiesmann A. Weller A. Lischka G. Klingebiel T. Kanz L. Einsele H. Bone Marrow Transplant 1999, 23: 151

Crossref Google Scholar
8 Kaufman KD. Erb DJ. Blok TM. Carlson RW. Knoechel DJ. McBride L. Zeitlow T. J. Heterocycl. Chem. 1982, 19: 1051

Google Scholar
9 Nore P. Honkanen E. J. Heterocycl. Chem. 1980, 17: 985

Google Scholar
10 Macleod JK. Worth BR. Tetrahedron Lett. 1972, 237

Crossref Google Scholar
11a Esse RC. Christensen BE. J. Org. Chem. 1960, 25: 1565

Google Scholar
11b Abu-Shady H. Hassib ST. Amin KM. Farag AE. Egypt. J. Pharm. Sci. 1990, 31: 453

Google Scholar
12 Zubia E. Luis FR. Massanet GM. Collado IG. Tetrahedron 1992, 48: 4239

Crossref Google Scholar
13a Ahluwalia VK. Prakash C. Bala S. Monatsh. Chem. 1980, 111: 877

Crossref Google Scholar
13b Aquila BM. Tetrahedron Lett. 1997, 38: 2795

Crossref Google Scholar
14 Hayakawa K. Yodo M. Ohsuki S. Kanematsu K. J. Am. Chem. Soc. 1984, 106: 6735

Crossref Google Scholar
15a Mal D. Bandhyopadhyay M. Datta K. Murty KVSN. Tetrahedron 1998, 54: 7525

Crossref Google Scholar
15b Mal D. Murty KVSN. Datta K. Tetrahedron Lett. 1994, 35: 9617

Crossref Google Scholar
16 Herndon JW. Zhang Y. Wang H. Wang K. Tetrahedron Lett. 2000, 41: 8687

Crossref Google Scholar
17 Nicolaou KC. Snyder SA. Bigot A. Pfefferkorn JA. Angew. Chem. Int. Ed. 2000, 39: 1093

Crossref Google Scholar
18a Roshchin AI. Kel’chevski SM. Bumagin NA. J. Organomet. Chem. 1998, 560: 163

Crossref Google Scholar
18b Youn SW. Eom JI. Org. Lett. 2005, 7: 3355

Crossref Google Scholar
19 Bellur E. Freifeld I. Langer P. Tetrahedron Lett. 2005, 46: 2185

Crossref Google Scholar
20 Tsai T. Wang E. Huang K. Li S. Wang Y. Lin Y. Chen Y. Heterocycles 2004, 63: 1771

Google Scholar
21 Majumdar KC. Basu PK. Mukhopadhyay PP. Tetrahedron 2005, 61: 10603

Crossref Google Scholar
22a Ballini R. Petrini M. Tetrahedron 2004, 60: 1017

Crossref Google Scholar
22b Van Tamelen EE. Thiede RJ. J. Am. Chem. Soc. 1952, 74: 2615

Crossref Google Scholar
22c Kornblum N. Erickson AS. Kelly WJ. Henggeler B. J. Org. Chem. 1982, 47: 4534

Crossref Google Scholar
22d McMurry JE. Melton J. J. Org. Chem. 1973, 38: 4367

Crossref Google Scholar
22e Keinan E. Mazur Y. J. Am. Chem. Soc. 1977, 99: 3861

Crossref Google Scholar
23 Dauzonne D. Royer R. Synthesis 1984, 1054

Article in Thieme Connect Google Scholar
28 Coleman PJ. Brashear KM. Askew BC. Hutchinson JH. McVean CA. Duong LT. Feuston BP. Fernandez-Metzler C. Gentile MA. Hartman GD. Kimmel DB. Leu CT. Lipfert L. Merkle K. Pennypacker B. Prueksaritanont T. Rodan GA. Wesolowski GA. Rodan SB. Duggan ME. J. Med. Chem. 2004, 47: 4829

Crossref PubMed Google Scholar
29 Chatterjee DK. Chatterje RM. Sen K. J. Org. Chem. 1964, 29: 2467

Google Scholar
30 Ahluwalia VK. Tripathi RP. J. Indian Chem. Soc. 1984, 61: 1023

Google Scholar
31a Topolski M. J. Org. Chem. 1995, 60: 5588

Crossref Google Scholar
31b Okuyama T. Fueno T. Bull. Chem. Soc. Jpn. 1974, 47: 1263

Crossref Google Scholar
31c Kelly TR. Szabados A. Lee YJ. J. Org. Chem. 1997, 62: 428

Crossref Google Scholar
31d Van Wijngaarden I. Kruse CG. Van der Heyden JAM. Tulp MTM. J. Med. Chem. 1988, 31: 1934

Crossref Google Scholar

24

Benzofuran 4: Compound 2 (2 mmol) was added to an aq soln of 2 M NaOH (15 mL) and stirred at r.t. for 30 min under an N₂ atmosphere. After cooling to 0 °C, the resultant solution was added dropwise to a well-stirred aq solution of 3 M H₂SO₄ (25 mL) at 0 °C. The reaction was stirred at r.t. for about 4 h until the reaction was complete. The solution was extracted with EtOAc and the organic phase was dried over anhyd Na₂SO₄. After removal of the solvent, the residue was purified by flash chromatography on silica gel to afford the desired compound 4. [28] Mp 54-55 °C. IR (KBr): 3423, 3122, 1602, 1446, 1132, 837 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.52 (d, J = 2.2 Hz, 1 H), 7.42 (d, J = 8.5 Hz, 1 H), 7.00 (m, 1 H), 6.79 (dd, J = 8.5 Hz, J = 2.2 Hz, 1 H), 6.69 (dd, J = 2.2 Hz, J = 0.9 Hz, 1 H), 5.16 (br s, 1 H). EI-MS: m/z (%) = 134 (M⁺, 100), 105(30), 78 (35), 51 (15). Anal. Calcd for C₈H₆O₂: C, 71.64; H, 4.51. Found: C, 71.57; H, 4.52.

25

5b-f; General Procedure: To a mixture of 4 and an appropriate β-ketoester (ratio 1:1.2), an excess of MsOH (0.5 mL per mmol of 4) was slowly added, and stirred at 0 °C for 30 min. Stirring was continued at r.t. until the reaction was complete (monitored by TLC). The resulting mixture was poured into ice-water, stirred for 1 h at r.t., extracted with EtOAc, the organic phase was dried over anhyd Na₂SO₄, and then concentrated in vacuo. The residue was purified by flash chromatography over silica gel (PE-acetone) to afford the title compounds 5b-f.
5b Yield: 72%; mp 186-187 °C (acetone) (lit. [29] 185-186 °C). IR (KBr): 3161, 1724, 1631, 1385, 746 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.82 (s, 1 H), 7.69 (d, J = 2.4 Hz, 1 H), 7.48 (d, J = 0.4 Hz, 1 H), 6.86 (dd, J = 2.4 Hz, J = 0.4 Hz, 1 H), 6.27 (s, 1 H), 2.51 (s, 3 H). EI-MS: m/z (%) = 200 (M⁺, 100), 172 (70), 171 (75), 144 (10), 115 (25).
5c Yield: 70%; mp 170-171 °C. IR (KBr): 3122, 2972, 1716, 1629, 1583, 1130 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.86 (s, 1 H), 7.69 (d, J = 2.4 Hz, 1 H), 7.49 (d, J = 0.8 Hz, 1 H), 6.84 (dd, J = 2.4 Hz, J = 0.8 Hz, 1 H), 6.28 (t, J = 1.2 Hz, 1 H), 2.89 (dq, J = 7.2 Hz, J = 1.2 Hz, 2 H), 1.38 (t, J = 7.2 Hz, 3 H). EI-MS: m/z (%) = 214 (M⁺, 75), 185 (30), 171 (100), 115 (15). Anal. Calcd for C₁₃H₁₀O₃: C, 72.89; H, 4.71. Found: C, 72.97; H, 4.65.
5d Yield: 65%; mp 127-128 °C (lit. [30] 128-129 °C). IR (KBr): 3112, 2955, 1708, 1630, 1576, 1161, 1112 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.84 (s, 1 H), 7.68 (d, J = 2.4 Hz, 1 H), 7.47 (s, 1 H), 6.84 (d, J = 2.4 Hz, 1 H), 6.25 (s, 1 H), 2.81 (t, J = 7.6 Hz, 2 H), 1.79 (m, 2 H), 1.08 (t, J = 7.6 Hz, 3 H). EI-MS: m/z (%) = 228 (M⁺, 100), 200(35), 185 (70), 171 (70), 115 (20).
5e Yield: 67%; mp 142-143 °C. IR (KBr): 3101, 1731, 1628, 1581, 1450, 1283, 1151 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.97 (q, J = 1.9 Hz, 1 H), 7.75 (d, J = 2.2 Hz, 1 H), 7.56 (d, J = 0.5 Hz, 1 H), 6.90 (dd, J = 2.2 Hz, J = 0.8 Hz, 1 H), 6.79 (s, 1 H). EI-MS: m/z (%) = 254 (M⁺, 90), 226 (100), 198 (20), 169 (20). Anal. Calcd for C₁₂H₅F₃O₃: C, 56.71; H, 1.98. Found: C, 56.67; H, 2.10.
5f Yield: 58%; mp 177-178 °C. IR (KBr): 3128, 3124, 1722, 1626, 1568, 1375, 1149 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.68 (s, 1 H), 7.67 (br s, 1 H), 7.57-7.47 (m, 6 H), 6.76 (dd, J = 2.2 Hz, J = 1.0 Hz, 1 H), 6.34 (s, 1 H). EI-MS: m/z (%) = 262 (M⁺, 90), 234 (100), 205 (35), 176 (30), 76 (20). Anal. Calcd for C₁₇H₁₀O₃: C, 77.85; H, 3.84. Found: C, 77.94; H, 3.92.

26

Psoralen 5a: A mixture of ZnCl₂ (210 mg, 1.5 mmol), ethyl propiolate (0.5 mL, 5 mmol), and compound 4 (134 mg, 1.0 mmol) was heated at 90 °C for 3 h under a N₂ atmosphere. After cooling to r.t., 5% HCl (25 mL) was added to the resultant mixture, which was then extracted with EtOAc
(3 × 25 mL). The combined organic layer was washed with H₂O (3 × 10 mL), brine (20 mL), and dried over anhyd Na₂SO₄. The solvent was removed on a rotary evaporator to yield the crude product which was purified by flash chromatography to give the desired compound 5a. Yield: 56%; mp 162-163 °C (lit. [13a] 161-162 °C). IR (KBr): 3157, 1720, 1633, 1286, 1136, 750 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.81 (d, J = 9.6 Hz, 1 H), 7.70 (d, J = 1.2 Hz, 1 H), 7.69 (s, 1 H), 7.49 (s, 1 H), 6.84 (d, J = 1.2 Hz, 1 H), 6.39 (d, J = 9.6 Hz, 1 H). EI-MS: m/z (%) = 186 (M⁺, 100), 158 (90), 130 (30), 102 (40).

27

9a: [31a] ¹H NMR (400 MHz, CDCl₃): δ = 7.62 (d, J = 1.6 Hz, 1 H), 7.57 (d, J = 10.0 Hz, 1 H), 7.51 (d, J = 8.4 Hz, 1 H), 7.30-7.27 (m, 2 H), 6.77 (d, J = 1.6 Hz, 1 H). EI-MS: m/z (%) = 118 (M⁺, 100), 78 (45).
9b: [31b] ¹H NMR (400 MHz, CDCl₃): δ = 7.52 (d, J = 2.4 Hz, 1 H), 7.43 (d, J = 9.1 Hz, 1 H), 7.00 (s, 1 H), 6.81 (d, J = 9.1 Hz, 1 H), 6.69 (d, J = 2.4 Hz, 1 H), 3.78 (s, 3 H). EI-MS: m/z (%) = 148 (M⁺, 100), 134 (25), 78 (15).
9c: [31c] ¹H NMR (400 MHz, CDCl₃): δ = 7.74 (s, 1 H), 7.63 (d, J = 2.3 Hz, 1 H), 7.39 (m, 2 H), 6.73 (d, J = 2.3 Hz, 1 H). EI-MS: m/z (%) = 197 (M⁺, 95), 196 (100), 78 (25).
9d: [31d] ¹H NMR (400 MHz, CDCl₃): δ = 8.16 (d, J = 10.3 Hz, 1 H), 7.95 (d, J = 8.6 Hz, 1 H), 7.86 (d, J = 2.4 Hz, 1 H), 7.42-7.37 (m, 1 H), 6.95 (d, J = 2.4 Hz, 1 H). EI-MS: m/z (%) = 163 (M⁺, 100), 105 (25), 78 (35).